Clinical trial · Interventional
Study of Geriatric Patients Aged 75 Years or Older Treated and Cured for Localized Prostate Cancer: Case-control Study
NCT01797692CI-TRIAL-00016976PROGEcompletedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This is a multicenter pilot study, proposed for cases and controls 3 departments in France. Cases are cured patients who have had prostate cancer for at least 10 years. Cookies are healthy subjects selected by lottery on voter list. Volunteer subjects (cases and controls) are offered a consultation and assessment with an geriatrician.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Healthy Population Control | — | UNRESOLVED | — |
| Prostate Cancer Cured | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| geriatric assessment | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- OTHER
- label
- geriatric assessment
- description
- geriatric assessment
- interventionNames
- Other: geriatric assessment
Primary outcomes (1)
- measure
- impact of treatments
- timeFrame
- 10 years after treatment for cancer prostate
- description
- The main objective of this study is to evaluate the impact of treatments and their effects on the autonomy of patients over 75 years have been treated and cured for prostate cancer.
Secondary outcomes (3)
- measure
- Evaluate the anxiety of patients and controls
- timeFrame
- 10 years after treatment for cancer prostate
Eligibility
Eligibility (as posted)
- Sex
- Male
- Minimum age
- 75 Years
Show eligibility criteria text
Inclusion Criteria for patients: * Patients aged 75 years or more * Patients with a personal history of prostate cancer with a diagnosis ≥ 10 years * Patients who received curative treatment (surgery, radiotherapy,hormone therapy, brachytherapy, technical ablative) for localized prostate cancer * Patients considered cured of prostate cancer (regardless of initial treatment) * Patients with previously agreed to participate in a case-control study in the general population (study QALIPRO) as a case and volunteer to receive an assessment of geriatric * Signature of consent * Affiliation to a social security system Exclusion Criteria for patients: * Patients under 75 years * Patients with recurrent or metastatic * Persons deprived of liberty or under guardianship Inclusion Criteria for control population: * Male subjects * Subjects of 75 years or more * Subjects that do not have cancer or a history of cancer (except basal cell skin cancer) * Subject has previously agreed to participate in a case-control study in the general population (study QALIPRO) as a voluntary witness and to benefit from a balance oncogeriatrics * Subjects who gave their written consent to participate in the study
References
Publications (0)
Data not yet available
No reference posted for this study.